We partner with BioMed Central's open access journal, Molecular Neurodegeneration (MN), which is the official journal of BrightFocus. The open access publishing model provides free articles to the general public, as well as scientists, clinicians, and other healthcare practitioners.
MN publishes peer-reviewed, original scientific research on the causes of neurodegenerative diseases, such as Alzheimer's or Parkinson' and on the pre-clinical testing of potential therapies for these devastating diseases.
MN has animpact scoreof 6.56., meaning the journal is now the highest ranking open access neuroscience journal in the journal citation reports (JCR).
Reading One’s Mind in a Drop of Blood
Understanding the biological alterations that underlie neurodegenerative diseases, such as Alzheimer's disease, is crucial for our ability to develop treatment strategies, of which we currently have very few. A new study, published in Molecular Neurodegeneration by Dr. Philipp Jaeger and colleagues, including senior author and BrightFocus Scientific Review Committee member, Dr. Tony Wyss-Coray, now shows that blood may come to the rescue.